NASDAQ:CARA - Cara Therapeutics Price Target & Analyst Ratings Sign in or create an account to add this stock to your watchlist. Get Started $16.54 -0.36 (-2.13 %) (As of 02/20/2019 04:00 PM ET)Previous Close$16.90Today's Range$16.28 - $16.9152-Week Range$11.46 - $24.30Volume527,710 shsAverage Volume619,049 shsMarket Capitalization$649.86 millionP/E Ratio-8.89Dividend YieldN/ABeta2.87 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Analyst Ratings Cara Therapeutics (NASDAQ:CARA) Price Target and Consensus Rating (How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.11 Wall Street analysts have issued ratings and price targets for Cara Therapeutics in the last 12 months. Their average twelve-month price target is $24.7360, suggesting that the stock has a possible upside of 49.55%. The high price target for CARA is $30.00 and the low price target for CARA is $13.36. There are currently 1 hold rating and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."Today30 Days Ago90 Days Ago180 Days AgoConsensus Rating: BuyBuyBuyBuyConsensus Rating Score: 2.912.913.002.80Ratings Breakdown: 0 Sell Rating(s)1 Hold Rating(s)10 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)1 Hold Rating(s)10 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)0 Hold Rating(s)9 Buy Rating(s)0 Strong Buy Rating(s)0 Sell Rating(s)2 Hold Rating(s)8 Buy Rating(s)0 Strong Buy Rating(s)Consensus Price Target: $24.7360$25.5360$26.1111$25.8636Price Target Upside: 49.55% upside68.78% upside32.41% upside40.41% upsideCara Therapeutics (NASDAQ:CARA) Consensus Price Target History Cara Therapeutics (NASDAQ:CARA) Analyst Ratings History Show: Only the Most Recent Rating From Each Brokerage All Ratings For This Stock DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails2/6/2019Jefferies Financial GroupInitiated CoverageBuy$22.00Low1/15/2019Bank of AmericaInitiated CoverageNeutral$19.00Low12/20/2018HC WainwrightSet Price TargetBuy$30.00Low12/20/2018LaidlawSet Price TargetBuy$30.00Low12/20/2018Canaccord GenuitySet Price TargetBuy$25.00Low12/20/2018Piper Jaffray CompaniesSet Price TargetBuy$27.00Low12/20/2018Janney Montgomery ScottInitiated CoverageBuy$27.00 ➝ $13.36High11/7/2018Cantor FitzgeraldSet Price TargetBuy$27.00High8/8/2018Stifel NicolausBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.00High6/27/2018Needham & Company LLCBoost Price TargetPositive ➝ Buy$23.00 ➝ $28.00High3/16/2018Seaport Global SecuritiesReiterated RatingBuyLow11/7/2017Raymond JamesBoost Price TargetMarket Perform$25.00 ➝ $26.00N/A11/7/2017CIBCLower Price Target$26.00 ➝ $24.00N/A11/7/2017BMO Capital MarketsReiterated RatingMarket Perform$25.00N/A10/17/2017ScotiabankBoost Price TargetOutperform$31.00 ➝ $31.50N/A8/3/2017Royal Bank of CanadaLower Price TargetOutperform$31.00 ➝ $29.00Low(Data available from 2/20/2017 forward) This page was last updated on 2/20/2019 by MarketBeat.com StaffFeatured Article: How Do Front-End Loads Impact an Investment?